Jeng Wei

Jeng Wei

Auto-generated profile, based on publicly available information

Jeng Wei

Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
WYWei‑Hsian Yin
Wei‑Hsian Yin
JWJeng Wei
Jeng Wei
STShen-Kou Tsai
Shen-Kou Tsai
MHMing C. Hsiung
Ming C. Hsiung
YLYung-Tsai Lee
Yung-Tsai Lee
COChing-Huei Ou
Ching-Huei Ou
Background:Ascending aortic pseudoaneurysm (PsA) is an uncommon but surgically challenging problem with high morbidity and mortality. Herein we describe the efficacy and safety of the different approaches to transcatheter intervention for repair of ascending PsA and assess the selection of occluder devices using real-time 3-dimensional (RT 3D) color Doppler transesophageal echocardiography (TEE).Methods and Results:Three patients with complex ascending PsA after cardiac or aortic root surgery were treated with transcatheter intervention due to high risk for redo surgery. Perioperative RT 3D-TEE combined with fluoroscopy was used for monitoring. All ascending PsA were successfully occluded with different devices using the transcatheter technique either with the transapical, transarterial approach, or transvenous combined with hybrid process depending on lesion anatomy.Conclusions:Treatment of complex ascending PsA with transcatheter or combined hybrid intervention with cautious planning based on patient presentation and well-coordinated teamwork was successful. RT 3D color Doppler TEE provided precise information for the selection of appropriate occluder device, and also facilitated the procedure by guiding the catheter through difficult anatomy. (Circ J 2014; 78: 2215–2218)

19 August 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
YCYi-Wen Chen
Yi-Wen Chen
JWJeng Wei
Jeng Wei
HCHwei-Ling Chen
Hwei-Ling Chen
CCChing-Hui Cheng
Ching-Hui Cheng
IHI-Ching Hou
I-Ching Hou
Background: Heart transplantation (HTx) is the most effective treatment for end-stage heart failure patients. After transplantation, patients face physiological, psychological, social, and other health care problems. Mobile health (mHealth) apps can change the delivery of conventional health care to ubiquitous care and improve health care quality. However, a dearth of mHealth apps exists for patients with HTx worldwide, including in Taiwan. Objective: The aim of this study was to investigate the information needed and to develop a preliminary framework for an mHealth app for post-HTx patients. Methods: A qualitative approach with individual in-depth interviews was conducted at a heart center in the regional hospital of northern Taiwan from June to November 2017. Patients that had undergone HTx and their health professionals were recruited for purposeful sampling. A semistructured interview guideline was used for individual interviews and transcribed. Thematic analysis was used for data analysis. Results: A total of 21 subjects, including 17 patients and 4 health professionals, were recruited for the study. The following five major themes were identified: reminding, querying, experience sharing, diet, and expert consulting. Minor themes included a desire to use the app with artificial intelligence and integration with professional management. Conclusions: An intelligent mHealth app that addresses the five main themes and integrates the processes of using a mobile app could facilitate HTx self-management for Taiwanese patients.

1 March 2015 in Journal of the Chinese Medical Association
Verified
Journal Article
Open access
JWJeng Wei
Jeng Wei
WYWei‑Hsian Yin
Wei‑Hsian Yin
YLYung-Tsai Lee
Yung-Tsai Lee
MHMing C. Hsiung
Ming C. Hsiung
STShen-Kou Tsai
Shen-Kou Tsai
YCYi-Pen Chou
Yi-Pen Chou
Background Paravalvular leaks (PVLs) are a common complication of prosthetic valve replacement. Use of the transcatheter intervention technique is a suitable alternative in high-risk patients who may not tolerate repeat surgery. Common reasons for failure of this demanding intervention include poor imaging quality and unsuitable anatomy. The purpose of this study was to assess the usefulness and the incremental value of real-time three-dimensional (RT 3D) transesophageal echocardiography (TEE) over two-dimensional (2D) TEE findings in the evaluation of the geometry and track of mitral PVLs during transcatheter closure. Methods Five patients with six mitral PVLs at high risk for repeat surgery underwent transcatheter leak closure. Intraoperative RT 3DTEE was used to assess the location, shape, number, and size of the defects. Transapical approaches were used in all cases with fluoroscopic and RT 3D TEE guidance of the wire and catheter, device positioning, and assessment of residual leak after the procedure. Results In all of the cases, defects with irregular crescent shapes and distorted tracks were clearly delineated by RT 3D TEE. This was compared to those results obtained through 2D TEE, which was unable to characterize the defects. Three cases showed small leaks, which were completely occluded with a patent ductus arteriosus (PDA) device in two cases, and a muscular ventricular septal defect (mVSD) occluder combined with coil devices in one case. One case involved a large leak and early device embolization of the muscular VSD occluder, which was removed surgically, and demonstrated a crescent–shaped defect. One patient had two releaks 2 months subsequent to the procedure due to two new extended leaks at the tails of the crescent–shaped defect. Conclusion RT 3D TEE can clearly delineate the geometries of defects in their entirety, including shape, size, and location of the defect and track canal. It would also appear that RT 3D TEE is superior to 2D TEE in the process of guiding the wire through the difficult canal anatomy, facilitating the overall procedure. The small mitral PVLs can be completely occluded, but subsequent complications occurred with large defect closures because of embolization or releak. Therefore, transcatheter closure of PVLs seems to be an attractive alternative for these patients, but newer occluder designs that better conform to leak geometry will be required to improve outcomes.

23 April 2010 in Heart & Lung
Verified
Journal Article
Closed access
PDF file
HTHeng-Hsin Tung
Heng-Hsin Tung
YCYun-Chia Chen
Yun-Chia Chen
JWJeng Wei
Jeng Wei
CLCHIEH-YU LIU
CHIEH-YU LIU
CCChung-Yi Chang
Chung-Yi Chang
TWTsae-Jyy Wang
Tsae-Jyy Wang

11 June 2021 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MHMing-Chon Hsiung
Ming-Chon Hsiung
WYWei-Hsian Yin
Wei-Hsian Yin
YLYung-Tsai Lee
Yung-Tsai Lee
TTTien-Ping Tsao
Tien-Ping Tsao
KLKuo-Chen Lee
Kuo-Chen Lee
JWJeng Wei
Jeng Wei
Purpose: In this study, transapical transcatheter mitral valve-in-valve implantation (TAMVI) was compared with surgical redo mitral valve replacement (SRMVR) in terms of clinical outcomes.Methods: We retrospectively identified patients with degenerated mitral bioprosthesis or failed annuloplasty rings who underwent redo SRMVR or TAMVI at our medical center. Clinical outcomes were based on echocardiography results.Results: We retrospectively identified patients with symptomatic mitral bioprosthetic valve dysfunction (n = 58) and failed annuloplasty rings (n = 14) who underwent redo SRMVR (n = 36) or TAMVI (n = 36). The Society of Thoracic Surgeons Predicted Risk of Mortality scores were higher in the TAMVI group (median: 9.52) than in the SRMVR group (median: 5.59) (p-value = 0.02). TAMVI patients were more severe in New York Heart Association (p-value = 0.04). The total procedure time (skin to skin) and length of stay after procedures were significantly shorter in the TAMVI group, and no significant difference in mortality was noted after adjustment for confounding factors (p-value = 0.11). The overall mean mitral valve pressure gradient was lower in the TAMVI group than in the SRMVR group at 24 months (p < 0.01). Both groups presented a decrease in the severity of mitral and tricuspid regurgitation at 3–24 months.Conclusions: In conclusion, the statistical analysis is still not robust enough to make a claim that TAMVI is an appropriate alternative. The outcome of the patient appears only to be related to the patient's pre-operative STS score. Additional multi-center, longitudinal studies are warranted to adequately assess the effect of TAMVI.

31 March 2020 in JMIR Preprints
Verified
Preprint
Open access
YCYi-Wen Chen
Yi-Wen Chen
JWJeng Wei
Jeng Wei
HCHwei-Ling Chen
Hwei-Ling Chen
CCChing-Hui Cheng
Ching-Hui Cheng
IHI-Ching Hou
I-Ching Hou
BACKGROUND Heart transplantation (HTx) is the most effective treatment for end-stage heart failure patients. After transplantation, patients face physiological, psychological, social, and other health care problems. Mobile health (mHealth) apps can change the delivery of conventional health care to ubiquitous care and improve health care quality. However, a dearth of mHealth apps exists for patients with HTx worldwide, including in Taiwan. OBJECTIVE The aim of this study was to investigate the information needed and to develop a preliminary framework for an mHealth app for post-HTx patients. METHODS A qualitative approach with individual in-depth interviews was conducted at a heart center in the regional hospital of northern Taiwan from June to November 2017. Patients that had undergone HTx and their health professionals were recruited for purposeful sampling. A semistructured interview guideline was used for individual interviews and transcribed. Thematic analysis was used for data analysis. RESULTS A total of 21 subjects, including 17 patients and 4 health professionals, were recruited for the study. The following five major themes were identified: reminding, querying, experience sharing, diet, and expert consulting. Minor themes included a desire to use the app with artificial intelligence and integration with professional management. CONCLUSIONS An intelligent mHealth app that addresses the five main themes and integrates the processes of using a mobile app could facilitate HTx self-management for Taiwanese patients.